Role of altered immune response in CF and implication for antiinflammatory therapies

H. Grasemann (Toronto, On, Canada)

Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Number: 15

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Grasemann (Toronto, On, Canada). Role of altered immune response in CF and implication for antiinflammatory therapies. Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012


Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014




Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009


Role of pharmacogenomics in host response to treatment
Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease
Year: 2004

Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation
Source: Eur Respir J, 54 (1) 1802390; 10.1183/13993003.02390-2018
Year: 2019



ICS/LABA effects on antiviral innate immune response. An in vitro analysis.
Source: International Congress 2019 – Novel targets and mechanisms in asthma
Year: 2019




Latent TGF-ß binding protein 4 is an important factor that influences anti-inflammatory and cell-protective responses in the pathogenesis of pulmonary emphysema
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020

Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019


The future of targeted therapies for sarcoidosis
Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis
Year: 2005

Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist
Source: Annual Congress 2011 - T-cell subsets
Year: 2011

Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018


Inflammatory phenotypes of asthma determine effect of inhaled corticosteroids on anti-viral immunity
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020




Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage
Source: Eur Respir J 2003; 22: Suppl. 45, 458s
Year: 2003

Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019



Polymorphisms of innate immune response genes and severe systemic inflammatory response syndromes
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006

T-cell susceptibility to glucocorticoid (GC)-induced apoptosis: the role in asthma pathogenesis and therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 227s
Year: 2006

Immunotherapy improves inflammatory cytokines, humoral immunity and cellular immunity in septic patients
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010


Immunology and defence mechanism of the developing lung
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60
Year: 2006